For drug development companies and investors
Invest with confidence — GATC Health’s Rated program
For drug development companies and investors
Augment drug candidate listings
Once a Provider has become a member of Bioneex and has listed one or more drug candidates, the Provider can take advantage of Bioneex’s partnership with GATC Health to participate in the GATC Rated™ program. A GATC Rated drug candidate provides potential investors with detailed insights into predicted safety, efficacy and side effect outcomes.
Join the elite ranks of GATC Health Rated assets
Once your drug candidate is GATC Rated, Bioneex will highlight your asset in the GATC Rated search results your drug candidate’s listing will feature the GATC Rated seal Bioneex & GATC will promote your asset’s rating in press announcements, media outreach, social media and promotional events.
Search for GATC Health Rated investments
Investors can search for GATC Rated investments using the Bioneex search dropdown menu. Results will include all drug assets that have received ratings from the program. The GATC Rated reports are owned by the drugmakers and can be shared with investment analysts upon request, providing valuable third-party insights into the drug candidate’s future performance.
Transact with confidence
The GATC Rated program runs on the GATC Health’s validated Multiomics Advanced Technology™ (MAT) AI platform, which replicates complex human systems biology using neural networks and machine learning to accurately and efficiently predict efficacy, safety, and off-target effects.
Deal
The GATC Rated program improves the due diligence process for both drug candidates and seekers by providing third-party insights into human safety, efficacy and off-target outcomes. Any reference to the GATC Rated™ program shall comply with the following Terms of Use.